- Pharmapack Europe unpacks key drivers and challenges in 2020
- PDC*line Pharma raises €20 M from Korean firms
- YMVSV invests in Australian health tech startup loop+
- Eisai’s DAYVIGO gets approval in Japan to treat insomnia
- ZTE conducts 5G diagnosis of coronavirus pneumonia
- CDD receives rare disease classification from WHO
- PerkinElmer unveils Advanced Drug Discovery and Disease Research Solutions
- Foxconn invests $26M in Nanox
- Amgen Astellas Biopharma to become wholly owned Amgen affiliate
- CEPI selects Inovio to develop vaccine against coronavirus
- Sartorius is set to grow further
- CO-Diagnostics prepares Coronavirus test
- I-MAB Announces Pricing of U.S. Initial Public Offering
- Veredus Lab develops test for coronavirus detection
-
World | 12 December 2019 | News
Researchers unfold genetic code that controls cell function and disease
A research team led by Queen’s University Belfast has made a breakthrough discovery around how and why o...Read more
Europe | 05 November 2019 | Influencers
TPP Commits To Transform The Delivery of Health and Care Globally
Nov Special Interview - Malaysia. TPP is a healthcare technology company, dedicated to delivering world...Read more
-
Europe | 28 January 2020 | News
Pharmapack Europe unpacks key drivers and challenges in 2020
Pharmapack Europe organised by Informa Markets, will take place next week at the Porte De Versailles in Paris ...Read more
-
Korea | 28 January 2020 | News
PDC*line Pharma raises €20 M from Korean firms
Belgium based PDC*line Pharma, a clinical stage biotech company developing a new class of potent and scalable ...Read more
-
Middle East countries | 16 July 2019 | News
Filterlex Medical raises $3M in Series A Financing
Filterlex Medical is a medical device start-up company based in Israel, developing an innovative embolic ...Read more
-
Thailand | 30 July 2019 | News
Thai startups to capture a major chunk of healthcare market
The medical device market in ASEAN is predicted to be worth US$8.5 billion by 2021, and Thai entrepreneurs wan...Read more
ACT TIMELY
In 2019, we saw Asia developing itself into a major hub for medtech and biopharma activities for both local as well multinational companies. Biotech companies in the region entered into partnerships with leading global biopharmaceutical companies on both the R&D and commercial fronts. Now, as we enter into 2020, the industry plans to further rise in the medtech, biopharma and startups space within Asia focusing on applied research, new technologies, affordability and manageability.
